Grant E. Blouse - 09 Feb 2022 Form 4 Insider Report for CATALYST BIOSCIENCES, INC. (GYRE)

Role
Chief Scientific Officer
Signature
/s/ Seline Miller, Attorney-in-Fact for Grant E. Blouse
Issuer symbol
GYRE
Transactions as of
09 Feb 2022
Net transactions value
+$1,495
Form type
4
Filing time
16 Feb 2022, 19:07:10 UTC
Previous filing
11 Aug 2021
Next filing
23 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CBIO Common Stock Purchase $1,495 +3,250 +111% $0.4600 6,167 09 Feb 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares purchased under the Issuer's 2018 Employee Stock Purchase Plan on February 9, 2022.